IC
AUPH icon

IEQ Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

IEQ Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,088
Closed -$327K – 2026
2026
Q1 		$327K Buy
22,088
+8,206
+59% +$120K ﹤0.01% 1482
2025
Q4 		$221K Buy
+13,882
New +$197K ﹤0.01% 1666
2025
Q2 		– Sell
-33,123
Closed -$266K – 1824
2025
Q1 		$266K Buy
+33,123
New +$268K ﹤0.01% 1237

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEQ Capital's AUPH Position: Q2 2026 in Review

IEQ Capital sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2026, closing a stake of 22,088 shares — an estimated $327K sold.

IEQ Capital first reported a position in AUPH in Q1 2025 and held it in 3 quarters. The position peaked at $327K in Q1 2026. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • IEQ Capital reported no remaining Aurinia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • IEQ Capital sold 22,088 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $327K.
  • IEQ Capital first reported a position in Aurinia Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • IEQ Capital's Aurinia Pharmaceuticals position peaked at $327K in Q1 2026.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.